Korean J Gynecol Oncol.  2007 Jun;18(2):160-164.

Malignant lymphoma of the uterine cervix treated by neoadjuvant chemotherapy

Affiliations
  • 1Department of Obstetrics and Gynecology, College of Medicine, Chungnam National University, Daejon, Korea. gustohwang@hanmail.net

Abstract

Non-Hodgkin's lymphoma presented as a malignancy of the uterine cervix is exceedingly rare disease and accounts for approximately only 0.12-0.6% of extranodal lymphomas. There is no consensus on the management and prognosis of the disease because of its extreme rarity. Previously, treatment of this disease has been radiation therapy, surgery or chemotherapy either alone or in combination. We present the case of a 45-year-old woman diagnosed with diffuse, large B-cell non-Hodgkin's lymphoma of the uterine cervix. We administered neoadjuvant chemotherapy according to CHOP protocol (cyclophosphamide, adriamycin, vincristine, and prednisone) followed by hysterectomy and bilateral salpingo-oophorectomy. The patient is alive 20 months after the initial diagnosis. We report the case with a brief review of literature.

Keyword

Lymphoma; Cervical lymphoma; Neoadjuvant chemotherapy

MeSH Terms

B-Lymphocytes
Cervix Uteri*
Consensus
Diagnosis
Doxorubicin
Drug Therapy*
Female
Humans
Hysterectomy
Lymphoma*
Lymphoma, Non-Hodgkin
Middle Aged
Prognosis
Rare Diseases
Vincristine
Doxorubicin
Vincristine
Full Text Links
  • KJGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr